Cryotherapy, a minimally invasive treatment for cervical precancerous lesions caused by HPV, uses extreme cold from nitrogen gas to destroy abnormal cells, preventing progression to cervical cancer. Recommended for mild to moderate dysplasia, it’s less effective for deeper lesions, where surgery may be needed. Patients should consult healthcare providers about medical history and arrange post-procedure transport due to possible lightheadedness, bringing menstrual pads for expected discharge.
During the outpatient procedure, a speculum exposes the cervix, and a cryoprobe freezes atypical cells, causing cold sensations and mild cramping that soon fade. Aftercare involves monitoring for bleeding, cramps, or infection, avoiding tampons, and reporting unusual symptoms. Pregnant patients post-treatment should inform their doctors, as further procedures might wait until after childbirth. Rare risks include infection or numbness.
While effective against precancerous cells, cryotherapy doesn’t cure HPV, requiring regular follow-ups to monitor cervical health. It’s a low-risk option, but patients must discuss benefits and protocols with providers to manage cervical cancer risks effectively.
